Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
The last decade has seen numerous outbreaks of Clostridium difficile-associated disease (CDAD), which presented significant challenges for healthcare facilities worldwide. We have identified and purified thuricin CD, a two-component antimicrobial that shows activity against C. difficile in the nanomolar range. Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates, including ribotypes commonly associated with CDAD (e.g., ribotype 027). However, this bacteriocin thuricin CD has little impact on most other genera, including many gastrointestinal commensals. Complete amino acid sequencing using infusion tandem mass spectrometry indicated that each peptide is posttranslationally modified at its respective 21st, 25th, and 28th residues. Solution NMR studies on [(13)C,(15)N] Trn-alpha and [(13)C,(15)N]Trn-beta were used to characterize these modifications. Analysis of multidimensional NOESY data shows that specific cysteines are linked to the alpha-carbons of the modified residues, forming three sulfur to alpha-carbon bridges. Complete sequencing of the thuricin CD gene cluster revealed genes capable of encoding two S'-adenosylmethionine proteins that are characteristically associated with unusual posttranslational modifications. Thuricin CD is a two-component antimicrobial peptide system with sulfur to alpha-carbon linkages, and it may have potential as a targeted therapy in the treatment of CDAD while also reducing collateral impact on the commensal flora.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and administration of a cocktail containing a member of Lachnospiraceae was reported to cure CDI in mice52.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 1×
“Although bacteriocins produced by LAB are the most widely investigated (9, 10), bacteriocins are also produced by most other Gram-positive (11–15) and Gram-negative (16, 17) bacterial species.”
BackgroundSelf-citationWishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., & Sykes, B. D. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00227471 · Cited by 1,628
Bacteriocins of lactic acid bacteria
Klaenhammer, T. R. (1988) · Biochimie · doi:10.1016/0300-9084(88)90206-4 · Cited by 1,539
Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., & Sykes, B. D. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00211764 · Cited by 1,012
Lantibiotics: structure, biosynthesis and mode of action
McAuliffe, O. (2001) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00065-6 · Cited by 700 · cited 2×
“4% identity) and also share similar features with a number of other double glycine leaders in Class I [type-A(II)] and class II bacteriocins (22).”
BackgroundSelf-citationS-adenosylmethionine: nothing goes to waste
Fontecave, M., Atta, M., & Mulliez, E. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.007 · Cited by 604 · cited 1×
“These enzymes generally generate catalytic radicals through the reductive cleavage of AdoMet by combining SAM and an unusual iron sulfur cluster (4Fe-4S) (25).”
BackgroundNarrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599 · cited 1×
“difficile (PCR ribotype 027) (5, 7) adds urgency to the search for alternative treatments for CDAD.”
BackgroundSchneider, E. (1998) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(98)00002-3 · Cited by 514 · cited 1×
“A perfect Walker A consensus motif beginning at Gly33 was identified (GX2GXGKS/T), and a Walker B site (hhhD; h is any hydrophobic residue) was located in the region of amino acid 152 (23) The TrnG protein is predicted to function as the N-terminal hydrophobic integral membrane domain, including six transmembrane α-he…”
BackgroundGenomics of the group of organisms
RASKO, D., ALTHERR, M., HAN, C., & RAVEL, J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.005 · Cited by 470
Identification of Clostridium difficile as a cause of pseudomembranous colitis.
George, R. H., Symonds, J. M., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R., Alexander-Williams, J., & Burdon, D. W. (1978) · BMJ · doi:10.1136/bmj.1.6114.695 · Cited by 451 · cited 1×
“difficile was recognized as a causative agent of nosocomial diarrhea in the 1970s (1), and is now a common occurrence, and cases of Clostridium difficile-associated disease (CDAD) are increasing both in numbers and severity in many parts of the world (2, 3).”
BackgroundWistrom, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 448
Increase in Clostridium difficile–related Mortality Rates, United States, 1999–2004
Redelings, M. D., Sorvillo, F., & Mascola, L. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1309.061116 · Cited by 429 · cited 1×
“difficile was recognized as a causative agent of nosocomial diarrhea in the 1970s (1), and is now a common occurrence, and cases of Clostridium difficile-associated disease (CDAD) are increasing both in numbers and severity in many parts of the world (2, 3).”
BackgroundAronsson, B., Mollby, R., & Nord, C. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.476 · Cited by 245
LIMITING FACTORS IN THE LACTIC FERMENTATION
Rogers, L. A., & Whittier, E. O. (1928) · Journal of Bacteriology · doi:10.1128/jb.16.4.211-229.1928 · Cited by 235 · cited 1×
“lactis that is used commercially in food preservation, has a broad spectrum of activity against other lactic acid bacteria (LAB) and most Gram-positive organisms (8).”
BackgroundKawulka, K. E., Sprules, T., Diaper, C. M., Whittal, R. M., McKay, R. T., Mercier, P., Zuber, P., & Vederas, J. C. (2004) · Biochemistry · doi:10.1021/bi0359527 · Cited by 203 · cited 1×
“There has been only one other report of sulfur to α-carbon linkages in a naturally occurring peptide, the antimicrobial subtilosin A (29).”
BackgroundSelf-citationAntimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains
Rea, M. C., Clayton, E., O'Connor, P. M., Shanahan, F., Kiely, B., Ross, R. P., & Hill, C. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47085-0 · Cited by 186 · cited 18×
“A potential problem associated with using traditional broad-spectrum antibiotics to treat CDAD is that these drugs will cause perturbations in the gut flora, a phenomenon that is likely to impede recovery and may even promote a recurrence of the disease.”
BackgroundMethodSelf-citationCherif, A., Ouzari, H., Daffonchio, D. G., Chérif, H., Slama, K. B., Hassen, A., Jaoua, S., & Boudabous, A. (2001) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2001.00898.x · Cited by 153
Clostridium difficile: changing epidemiology and new treatment options
Kuijper, E. J., van Dissel, J. T., & Wilcox, M. H. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32818be71d · Cited by 135 · cited 1×
“difficile (PCR ribotype 027) (5, 7) adds urgency to the search for alternative treatments for CDAD.”
BackgroundZheng, G., Hehn, R., & Zuber, P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3266-3273.2000 · Cited by 114 · cited 1×
“Radical SAM enzymes rarely occur in bacteriocin gene clusters, but they are included in those of subtilosin A and propiocin F (26, 27).”
BackgroundCherif, A., Chehimi, S., Limem, F., Hansen, B. M., Hendriksen, N. B., Daffonchio, D. G., & Boudabous, A. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02089.x · Cited by 111
In-Vitro Activity of Nisin Against Clinical Isolates of Clostridium difficile
Bartoloni, A., Mantella, A., Goldstein, B. P., Dei, R., Benedetti, M., Sbaragli, S., & Paradisi, F. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.2.119 · Cited by 84 · cited 14×
“A potential problem associated with using traditional broad-spectrum antibiotics to treat CDAD is that these drugs will cause perturbations in the gut flora, a phenomenon that is likely to impede recovery and may even promote a recurrence of the disease.”
BackgroundInfluentialIsolation and characterisation of a novel bacteriocin produced byBacillus thuringiensisstrain B439
Ahern, M., Verschueren, S., & van Sinderen, D. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00086-7 · Cited by 83
Purification and partial chemical characterization of the antimicrobial peptide cerein 8A
Bizani, D., Dominguez, A. P. M., & Brandelli, A. (2005) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2005.01748.x · Cited by 77
Brede, D. A., Faye, T., Johnsborg, O., Ødegård, I., Nes, I. F., & Holo, H. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.12.7303-7310.2004 · Cited by 61 · cited 1×
“Radical SAM enzymes rarely occur in bacteriocin gene clusters, but they are included in those of subtilosin A and propiocin F (26, 27).”
BackgroundChehimi, S., Delalande, F., Sablé, S., Hajlaoui, M. R., DORSSELAER, A. V., Limam, F., & Pons, A. (2007) · Canadian Journal of Microbiology · doi:10.1139/w06-116 · Cited by 54
Colicins prevent colonization of urinary catheters
Trautner, B. W., Hull, R. A., & Darouiche, R. O. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki228 · Cited by 43
Browne, B. L., McClendon, V., & Bedwell, D. M. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.6.1712-1719.1996 · Cited by 32 · cited 1×
“Because two copies of each domain are required for functionality, it is expected that both proteins dimerize at the cytoplasmic membrane to form an active translocation complex (24).”
BackgroundA new group of parasporal inclusions encoded by the S-layer gene of Bacillus thuringiensis.
Guo, G., Zhang, L., Zhou, Z., Ma, Q.-Q., Liu, J.-P., Zhu, C., Zhu, L., Yu, Z.-N., & Sun, M. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01087.x · Cited by 21 · cited 1×
“thuringiensis strains in which the inclusion is encoded by the slp gene and quickly degrades on cell lysis (21).”
BackgroundPadilla, C., Olga Lobos, G., Brevis, P., Paulina Abaca, C., & Hubert, E. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2005.01829.x · Cited by 16 · cited 4×
“Thuricin CD showed no activity against any Gram-negative organisms tested, including Escherichia coli, Pseudomonas sp., Salmonella sp., and Bacteroides fragilis.”
BackgroundInfluential
Research works printed but not linked: 4
- ; Center for Infections Mandatory Surveillance Team Health Protection Agency Summary points and commentary on quarterly calendar year and financial year Clostridium difficile data derived from Mandatory Surveillance. January 2009. Available at http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733750761?p=1179745282408. Accessed April 8 2010. (2009).
- 10.1016/j.fmrre.2004.12.005 · doi:10.1016/j.fmrre.2004.12.005 · Paper page
- 10.1111/j.1574-6976.2001.tb00579.x · doi:10.1111/j.1574-6976.2001.tb00579.x · Paper page
- 10.1111/j.1574-6976.1998.tb00358.x · doi:10.1111/j.1574-6976.1998.tb00358.x · Paper page
Cited by
Rethinking amide bond synthesis
Pattabiraman, V. R., & Bode, J. W. (2011) · Nature · doi:10.1038/nature10702 · Cited by 2,164
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
Self-citationPrecision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
“The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant enterococci.”
BackgroundSelf-citationMicrobiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Metadata
- Authors
- Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C.
- Affiliations
- Teagasc - The Irish Agriculture and Food Development Authority (IE)
- University of Alberta (CA)
- Biotechnology Department, Teagasc, Moorepark Food Research Centre, Fermoy, Ireland;
- University College Cork (IE)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-30
- Volume
- 107
- Issue
- 20
- Pages
- 9352-9357
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889069
- OpenAlex
- W2069812362
- Cited by
- 530
- References
- 30
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 34 · 2023: 30 · 2022: 46 · 2021: 41 · 2020: 44 · 2019: 39 · 2018: 39 · 2017: 34 · 2016: 30 · 2015: 32 · 2014: 32 · 2013: 22 · 2012: 21
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Alberta
- Science Foundation Ireland
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- bacteriocins, Clostridium difficile, Clostridium difficile-associated disease, Bacillus thuringiensis, post-translational modification, ribotype 027, ribosome-inactivating proteins, targeted antimicrobial therapy, commensal bacteria
- MeSH terms
- Amino Acid Sequence, Anti-Bacterial Agents, Bacillus thuringiensis, Bacteriocins, Feces, Humans, Molecular Sequence Data, Protein Processing, Post-Translational, S-Adenosylmethionine, Clostridioides difficile, Nuclear Magnetic Resonance, Biomolecular, Sequence Analysis, Protein, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.